A randomized phase III study of maintenance therapy with TS-1 plus best supportive care versus best supportive care after induction therapy with carboplatin plus TS-1 for advanced or relapsed squamous cell carcinoma of the lung

Trial Profile

A randomized phase III study of maintenance therapy with TS-1 plus best supportive care versus best supportive care after induction therapy with carboplatin plus TS-1 for advanced or relapsed squamous cell carcinoma of the lung

Recruiting
Phase of Trial: Phase III

Latest Information Update: 22 Oct 2014

At a glance

  • Drugs Gimeracil/oteracil/tegafur (Primary)
  • Indications Lung cancer; Squamous cell cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 22 Oct 2014 According to UMIN, inclusion criteria has been modified to include patients with postoperative recurrence of squamous cell carcinoma of the lung.
    • 09 Apr 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top